LGVN
Longeveron LLC
NASDAQ: LGVN · HEALTHCARE · BIOTECHNOLOGY
$0.85
-1.74% today
Updated 2026-04-30
Market cap
$26.35M
P/E ratio
—
P/S ratio
21.98x
EPS (TTM)
$-1.29
Dividend yield
—
52W range
$0 – $2
Volume
6.9M
Longeveron LLC (LGVN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |